Search

Go behind the scenes with Filemon Dela Cruz, who cares for children with sarcoma and conducts precision medicine research at Memorial Sloan Kettering.

… Monday, September 17, 2018 Summary Precision oncology is based on the idea that people can be treated according to the genetic changes that cause a tumor to grow and spread. At Memorial Sloan Kettering, this area of medicine is helping both children and adults. Here, pediatric sarcoma specialist Filemon

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.

… Monday, September 9, 2013 Summary Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable. A new international study led by physicians and scientists from Memorial Sloan Kettering has discovered a gene mutation linked

A new MSK study finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The findings could help improve immunotherapy treatment for the majority of patients with colorectal cancer, and potentially for other cancers.

… Monday, December 15, 2025 In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system’s ability to fight against a tumor. Colorectal cancer, however, is a puzzling exception. A high density of Treg cells in colorectal tumors

Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.

… Tuesday, February 4, 2020 Summary Larry Norton, Senior Vice President at Memorial Sloan Kettering, discusses some of the biggest achievements in cancer care made between 2010 and 2019, and what he hopes to see next. In January, the American Cancer Society reported that the rate of cancer deaths in the

Read about MSK research that sheds light on how the innate immune system interacts with developing cancer cells.

… Monday, October 6, 2025 Understanding the interaction between immune cells and cancer cells has important implications for  cancer immunotherapies , including  checkpoint inhibitor drugs and cell-based therapies, as well as newer treatments like  cancer vaccines . Over the last decade,  computational

Isabel Lam, a 2016 alumnae of Gerstner Sloan Kettering, has been awarded the Chairman’s Prize for her first-author paper “Nonparadoxical evolutionary stability of the recombination initiation landscape in yeast,” published in Science in 2015.

… Friday, July 29, 2016 Isabel Lam , a 2016 alumnae of Gerstner Sloan Kettering, has been awarded the Chairman’s Prize for her first-author paper “ Nonparadoxical evolutionary stability of the recombination initiation landscape in yeast ,” published in Science in 2015. Isabel completed her graduate research

Developmental biologist Dr. Alexandra Joyner reflects on her career and talks about the new passions she looks forward to pursuing in retirement.

… Tuesday, March 25, 2025 Alexandra Joyner, PhD , a member of the  Developmental Biology Program in the  Sloan Kettering Institute of Memorial Sloan Kettering Cancer Center (MSK), is retiring this year, following an illustrious 40-plus-year career. An expert in mammalian (mouse) developmental genetics,

New MSK research finds the TCA cycle’s waste-management function may present an opportunity against cancer; shows how microplastics impair immune ‘housekeeping’ functions; reveals the way the protein TOX plays different roles in different immune cells; and identifies a new combination approach for treating advanced kidney cancer after immunotherapy.

… Monday, March 2, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) shows how microplastics impair immune ‘housekeeping’ functions; finds the TCA cycle’s waste-management function may present an opportunity against cancer; reveals the way the protein TOX plays different roles in different

Dr. Gary Deng of the Integrative Medicine Service helps separate the hype from the proven health benefits of mushroom supplements.

… Tuesday, October 22, 2024 Mushrooms have always had an aura of special power about them. People all over the world have used them as medicine in the treatment of infection, lung disease, cancer, and other conditions for thousands of years. They have long been central to traditional medicine throughout

MSK Kids, the pediatric oncology program at MSK, is committed to shining a light on pediatric cancer. While there is a significant threat to pediatric cancer research stemming from COVID-19’s impact on philanthropy, several organizations helped MSK recognize pediatric cancer awareness month by fundraising for MSK Kids.

… Friday, October 16, 2020 MSK Kids, the pediatric oncology program at MSK, is committed to shining a light on pediatric cancer. Our clinicians and care teams are engaged in groundbreaking research that will continue to create tomorrow’s breakthroughs. While there is a significant threat to pediatric cancer